News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Inna D'Empaire, MD

Articles by Inna D'Empaire, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

Busting ADHD Myths at APSARD

APSARD 2026: Emerging Data Challenge Long-Held Concerns About ADHD Treatment

Do ADHD Stimulant Medications Have an Effect on Substance Use?

A New Lens on Pharmacotherapy for ADHD in Pregnancy

Precision Medicine for Opioid Use Disorder: Insights From New Review